Following U.S. Stocks Are Leading the Market Today in the course of recent trading session, Friday: FXCM Inc (NYSE:FXCM), Genetic Technologies Limited (ADR) (NASDAQ:GENE), El Pollo LoCo Holdings Inc (NASDAQ:LOCO), Ulta Salon, Cosmetics & Fragrance, Inc (NASDAQ:ULTA)
- FXCM Inc (NYSE:FXCM), with shares surged 24.65% is now trading at $2.67. The Stock is active as 11.78M shares changed hands versus its average volume of 4.10M shares.
- Genetic Technologies Limited (ADR) (NASDAQ:GENE), with shares raised 13.18% is now trading at $4.98. The Stock is active as 3.54M shares changed hands versus its average volume of 9.10M shares.
- El Pollo LoCo Holdings Inc (NASDAQ:LOCO) with shares enhanced 11.42% is now trading at $26.90. The Stock is active as 3.76M shares changed hands versus its average volume of 774,474.00 shares.
- Ulta Salon, Cosmetics & Fragrance, Inc (NASDAQ:ULTA), with shares rose 5.09% is now trading at $152.19. The Stock is active as 1.62M shares changed hands versus its average volume of 675,327.00 shares.
Latest NEWS regarding these Stocks are depicted underneath:
FXCM Inc. (NYSE:FXCM)
FXCM Inc. (NYSE:FXCM), a leading online provider of foreign exchange, or FX, trading and related services, declared for the quarter ended December 31, 2014, U.S. GAAP proceeds of $134.7 million, contrast to $113.3 million for the quarter ended December 31, 2013, an raise of 19%. U.S. GAAP net revenue attributable to FXCM Inc. was $15.8 million for the fourth quarter 2014 or $0.35 per fully diluted share, contrast to U.S. GAAP net revenue of $3.0 million or $0.08 per fully diluted share for the fourth quarter 2013.
For the twelve months ended December 31, 2014, U.S. GAAP proceeds were $463.8 million, contrast to $489.6 million for the twelve months ended December 31, 2013, a decrease of 5%. U.S. GAAP net revenue attributable to FXCM Inc. was $17.2 million for the twelve months ended December 31, 2014 or $0.39 per fully diluted share, contrast to U.S. GAAP net revenue of $14.8 million or $0.44 per fully diluted share for the twelve months ended December 31, 2013, an raise of 16% and decrease of 11% respectively.
Adjusted EBITDA for the fourth quarter 2014 was $40.8 million, contrast to $26.8 million for the fourth quarter 2013, an raise of 53%. Net revenue on an adjusted basis was $16.1 million or $0.20 per fully diluted, fully exchanged share for the fourth quarter 2014, contrast to Net revenue on an adjusted basis of $7.3 million or $0.10 per fully diluted, fully exchanged share for the fourth quarter 2013, an raise of 120% and 100% respectively.
Adjusted EBITDA for the twelve months ended December 31, 2014 was $107.3 million, contrast to $158.0 million for the twelve months ended December 31, 2013, a decrease of 32%. Net revenue on an adjusted basis was $28.2 million or $0.35 per fully diluted, fully exchanged share for the twelve months ended December 31, 2014, contrast to $57.8 million or $0.76 per fully diluted, fully exchanged share for the twelve months ended December 31, 2013, a decrease of 51% and 54% respectively.
Adjusted EBITDA, Net revenue on an adjusted basis and Net revenue on an adjusted basis per fully diluted, fully exchanged share are Non-GAAP financial measures. These measures do not represent and should not be considered as a substitute for net revenue, net revenue attributable to FXCM Inc. or net revenue per Class A share or as a substitute for cash flow from operating activities, each as determined in accordance with U.S. GAAP, and our calculations of these measures may not be comparable to similarly entitled measures stated by other companies. See “Non-GAAP Financial Measures” starting on A-3 of this release for additional information regarding these Non-GAAP financial measures and for reconciliations of such measures to the most directly comparable measures calculated in accordance with U.S. GAAP.
FXCM Inc., through its auxiliaries, provides online foreign exchange (FX) trading and related services to retail and institutional customers worldwide.
Genetic Technologies Limited (NASDAQ:GENE)
Looking into the Financial Highlights of Genetic Technologies Limited (GENE), then we come to know that its last fiscal year ended on Jun 30, and the most recent quarter ended on Dec 31, 2014. For the trailing twelve months, Profit Margin of the stock decreases -259.47% and operating margin declined almost -277.84% . On the other hand, return on assets value dwindled almost -70.75%. and return on equity value reduced by -260.06% for the trailing twelve months. The stock has outstanding shares of 5.66M, and is recently trading with the volume of 3,992,174 as compared to its average volume of 4,589,180. The company has the market capitalization of 27.33M.
Formerly on February 26, the molecular diagnostic company advised that Mr. Eutillio Buccilli has been designated Chief Executive Officer of the Corporation following the resignation of Ms. Alison Mew which was effective 31 December 2014.
Genetic Technologies is a molecular diagnostics corporation that offers predictive testing and assessment tools to assist physicians proactively manage women’s health. The Corporation’s lead product, BREVAGenplus®, is a clinically validated risk assessment test for non-hereditary breast cancer and is first in its class.
El Pollo Loco Holdings, Inc. (NASDAQ:LOCO)
El Pollo Loco Holdings, Inc. (LOCO), declared financial results for the 14-week and 53-week periods ended December 31, 2014.
Highlights for the 14-week fourth quarter ended December 31, 2014, contrast to the 13-week fourth quarter ended December 25, 2013 were as follows:
Total proceed was $90.0 million contrast to $76.2 million. On a comparable 13-week basis, total proceed raised 11.9%.
System-wide comparable restaurant sales grew 7.6%, counting a 6.4% raise for corporation-operated restaurants, and an 8.6% raise for franchised restaurants.
Net revenue was $4.6 million, or $0.12 per diluted share, contrast to a net loss of $18.1 million, or ($0.63) per diluted share.
Pro forma net revenue raised 60.6% to $5.5 million, or $0.14 per diluted share, contrast to $3.4 million, or $0.09 per diluted share. Fourth quarter 2014 results comprised of an estimated $0.01 per share positive influence due to the extra week in the quarter.
Adjusted EBITDA raised 29.4% to $16.3 million. Adjusted EBITDA in the fourth quarter of 2014 comprised of an estimated $1.0 million benefit from the extra week in the quarter.
Fourth Quarter 2014 Financial Results:
Corporation-operated restaurant proceed in the fourth quarter of 2014 raised 18.0% to $84.1 million, from $71.3 million in the same period last year. The Corporation’s fourth quarter of 2014 comprised of 14 weeks contrast to 13 weeks in the fourth quarter of 2013. Corporation-operated restaurant proceed in the fourth quarter of 2014 attributed to the extra week totaled about $4.6 million.
Comparable corporation-operated restaurant sales in the fourth quarter raised 6.4%, driven by a 3.3% rise in average check and a 3.1% raise in traffic.
Franchise proceed in the fourth quarter of 2014 raised 18.5% to $5.9 million, from $5.0 million in the fourth quarter of 2013. Franchised comparable restaurant sales raised 8.6% during the quarter.
Restaurant contribution raised 29.3% to $18.8 million, from $14.5 million in the fourth quarter of 2013. As a percent of corporation-operated restaurant proceed, restaurant contribution margin improved 195 basis points to 22.3%. The improvement in restaurant contribution margin was driven by leverage of comparable corporation-operated restaurant sales growth in addition to 40 basis points from operating leverage obtained from the extra operating week in the fourth quarter of 2014.
Net revenue for the fourth quarter of 2014 was $4.6 million, or $0.12 per diluted share, contrast to a net loss of $18.1 million, or $(0.63) per diluted share in the fourth quarter of 2013.
Pro forma net revenue raised 60.6% to $5.5 million, or $0.14 per diluted share during the fourth quarter of 2014, contrast to $3.4 million, or $0.09 per diluted share during the fourth quarter of 2013. Fourth quarter 2014 results comprised of an estimated $0.01 per share positive influence due to the extra week in the quarter. A reconciliation between GAAP net revenue and pro forma net revenue is comprised of in the accompanying financial data.
El Pollo Loco Holdings, Inc., through its partner, El Pollo Loco, Inc., develops, franchises, licenses, and operates quick-service restaurants under the El Pollo Loco name in the United States.
ULTA Salon, Cosmetics & Fragrance, Inc. (NASDAQ:ULTA)
ULTA Salon, Cosmetics & Fragrance, Inc. (ULTA), declared financial results for the thirteen week period and fifty-two week period ended January 31, 2015, which compares to the same periods ended February 1, 2014.
For the Fourth Quarter:
- Net sales raised 20.7% to $1,047.6 million from $868.1 million in the fourth quarter of fiscal 2013;
- Comparable sales (sales for stores open at least 14 months and e-commerce sales) raised 11.1% contrast to an raise of 9.2% in the fourth quarter of fiscal 2013. The 11.1% same store sales raise was driven by 7.7% growth in transactions and 3.4% growth in average ticket;
- E-commerce sales grew 55.2%, representing 230 basis points of the total corporation same store sales raise of 11.1%;
- Salon sales raised 20.9%, and comparable salon sales grew 11.0%, contributing 10 basis points to the retail comparable sales raise of 8.8%;
- Gross profit reduced 40 basis points to 33.4% from 33.8% in the fourth quarter of fiscal 2013, driven by raised costs associated with the ULTAmate Rewards loyalty program and the influence of a higher mix of e-commerce sales;
- Selling, general and administrative (SG&A) expense as a percentage of net sales reduced 40 basis points to 20.1% contrast to 20.5% in the fourth quarter of 2013;
- Pre-opening expenses reduced to $1.6 million, contrast to $1.8 million in the fourth quarter of fiscal 2013. Real estate activity in the fourth quarter of fiscal 2014 comprised of 10 new stores contrast to 11 new stores in the fourth quarter of fiscal 2013;
- Operating revenue raised 20.4% to $137.5 million, or 13.1% of net sales, contrast to $114.1 million, or 13.1% of net sales, in the fourth quarter of fiscal 2013;
- Tax rate of 36.6% reflects a $0.02 per diluted share benefit related to a non-recurring tax adjustment;
- Net revenue raised 23.5% to $87.3 million contrast to $70.7 million in the fourth quarter of fiscal 2013. Net revenue raised 21.6% to $86.0 million not including the influence of a non-recurring tax adjustment; and
- Revenue per diluted share raised 23.9% to $1.35 contrast to $1.09 in the fourth quarter of fiscal 2013. Revenue per diluted share comprises a non-recurring tax adjustment of about $0.02 resulting in a lower effective tax rate contrast to the fourth quarter of fiscal 2013. Not including this tax benefit, revenue per diluted share raised 22.0% to $1.33.
ULTA Beauty (ULTA) is the largest beauty retailer in the United States and the premier beauty destination for cosmetics, fragrance, skin, hair care products and salon services. Since opening its first store 25 years ago, ULTA Beauty has grown to become the top national retailer providing All Things Beauty, All in One Place™.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
